Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Single-chain antibodies from camelids have served as powerful tools ranging from diagnostics and therapeutics to crystallization chaperones meant to study protein structure and function. In this study, we isolated a single-chain antibody from an Indian dromedary camel (ICab) immunized against a bacterial 14 helix transporter, NorC, from We identified this antibody in a yeast display screen built from mononuclear cells isolated from the immunized camel and purified the antibody from after refolding it from inclusion bodies. The X-ray structure of the antibody at 2.15 Å resolution revealed a unique feature within its CDR3 loop, which harbors a Zn-binding site that substitutes for a loop-stabilizing disulfide bond. We performed mutagenesis to compromise the Zn-binding site and observed that this change severely hampered antibody stability and its ability to interact with the antigen. The lack of bound Zn also made the CDR3 loop highly flexible, as observed in all-atom simulations. Using confocal imaging of NorC-expressing spheroplasts, we found that the ICab interacts with the extracellular surface of NorC. This suggests that the ICab could be a valuable tool for detecting methicillin-resistant strains that express efflux transporters such as NorC in hospital and community settings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952597PMC
http://dx.doi.org/10.1074/jbc.RA119.010902DOI Listing

Publication Analysis

Top Keywords

cdr3 loop
8
zn-binding site
8
antibody
6
isolation structural
4
structural characterization
4
characterization zn-bound
4
zn-bound single-domain
4
single-domain antibody
4
norc
4
antibody norc
4

Similar Publications

Anovel anti-B7-H3 nanobody and its DM1 conjugate with marked anti-tumor activity against esophageal squamous cell carcinoma.

Int J Biol Macromol

September 2025

Department of Clinical Oncology, Shenzhen Key Laboratory for cancer metastasis and personalized therapy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong 518053, China; Department of Clinical Oncology, The University of Hong Kong, Hong Kong 00852, China; Advanced Energy Science and

Esophageal squamous cell carcinoma (ESCC), a highly aggressive malignancy with poor therapeutic outcomes, currently lacks effective molecularly targeted therapies. Despite emerging interest in B7-H3 as an attractive tumor-specific target, its therapeutic potential in ESCC remains unexplored. This study investigates the feasibility and efficacy of B7-H3 targeting using nanobodies and their drug conjugates as a therapeutic strategy for ESCC.

View Article and Find Full Text PDF

Nanobodies: From Discovery to AI-Driven Design.

Biology (Basel)

May 2025

State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Fudan University, Shanghai 200433, China.

Nanobodies, derived from naturally occurring heavy-chain antibodies in camelids (VHHs) and sharks (Vs), are unique single-domain antibodies that have garnered significant attention in therapeutic, diagnostic, and biotechnological applications due to their small size, stability, and high specificity. This review first traces the historical discovery of nanobodies, highlighting key milestones in their isolation, characterization, and therapeutic development. We then explore their structure-function relationship, emphasizing features like their single-domain architecture and long CDR3 loop that contribute to their binding versatility.

View Article and Find Full Text PDF

Glycosaminoglycans (GAGs) are key ligands for proteins involved in physiological and pathological processes. Specific GAG-binding patterns are rarely identified, with the heparin pentasaccharide as an Antithrombin-III ligand being the best characterized. Generating glycan-specific antibodies is difficult due to their size, pattern dispersion, and flexibility.

View Article and Find Full Text PDF

scTCR-seq and HTS reveal a special novel TRBD2-TRBJ1 rearrangement in mammalian TRB CDR3 repertoire.

BMC Genomics

April 2025

Department of Immunology, Center of Immunomolecular Engineering, Innovation & Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi, China.

Mammalian T cell receptor (TCR) beta-chain (TRB) V-D-J rearrangement mainly follows the "12/23 rule", and the "D-J rearrangement preceding the V-(D-J) rearrangement". Owing to the physical position of the D-J-C cluster in the TRB locus, the TRBD2 (D2) gene cannot directly perform inversional rearrangement or deletional/loop-out rearrangement with the TRBJ1 (J1) gene. Our previous studies revealed a single reverse TRBV30 (TRBV31 in mice) gene in the mammalian TRB locus, which can cause indirect rearrangement of the D2 gene and J1 gene; however, the mechanism and proportion involved in germline gene rearrangement are unknown.

View Article and Find Full Text PDF

Fibroblast activation protein alpha (FAP) is a serine protease that is expressed at basal levels in benign tissues but is overexpressed in a variety of pathologies, including cancer. Despite this unique expression profile, designing functional diagnostic and therapeutic agents that effectively target this biomarker remains elusive. Here we report the structural characterization of the interaction between a novel single domain antibody (sdAb), I3, and FAP using cryo-electron microscopy.

View Article and Find Full Text PDF